Find out how to tackle one of the biggest challenges in treating cancer with Genomic testing for cancer treatment Read more
Prof. Michael Untch, Head of Clinic for Gynecology, Gynecologic Oncology and Obstetrics, Head of Breast Interdisciplinary Cancer Center Department of Obstetrics and Gynecology, HELIOS Clinic Berlin-Buch in Berlin, Germany
Get more case studies
Get in touch
“Your EndoPredict result shows that your cancer is at low risk of recurrence”
“The EndoPredict score is based on the gene activity in your cancer and its risk profile”
“There is a 92% probability your cancer will not recurwithin 10 years”
“Chemotherapy reduces this risk of recurrence by 2%, but this small benefit may not outweigh the potential for side effects”